MHRA statement on Essure devices
Advice for women following the decision by Bayer to withdraw the Essure device from the European Market.
Bayer has advised the Medicines and Healthcare products Regulatory Agency that they are withdrawing the Essure Device from the European Market.
The manufacturer has advised this is a commercial decision and is not related to any safety concerns. They have also advised there is no need for women to have their device removed.
Patient safety is our highest priority and there is currently no evidence to suggest any increased risk to patient safety. Any women with questions should speak to their GP or healthcare professional.
We encourage any woman who has experienced a complication from her Essure device to report this to us through the Yellow Card scheme, regardless of how long ago the implant was inserted.
Media enquiries
News centre
MHRA
10 South Colonnade
London
E14 4PU
Email newscentre@mhra.gov.uk
During office hours: 020 3080 7651 (08:30 - 17:00)
Out of office hours: 07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk.